WEKO3
アイテム
Gadoxetic Acid-enhanced Liver MRI: Everything You Need to Know
http://hdl.handle.net/10271/0002000339
http://hdl.handle.net/10271/0002000339d6271a47-8c90-490d-8579-4d3ff91c5473
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
Invest Radiol-59-53.pdf (3 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2025-02-26 | |||||||||
| タイトル | ||||||||||
| タイトル | Gadoxetic Acid-enhanced Liver MRI: Everything You Need to Know | |||||||||
| 言語 | en | |||||||||
| 言語 | ||||||||||
| 言語 | eng | |||||||||
| キーワード | ||||||||||
| 主題 | magnetic resonance imaging | |||||||||
| キーワード | ||||||||||
| 主題 | gadoxetic acid | |||||||||
| キーワード | ||||||||||
| 主題 | liver | |||||||||
| キーワード | ||||||||||
| 主題 | hepatocellular carcinoma | |||||||||
| キーワード | ||||||||||
| 主題 | hepatobiliary phase | |||||||||
| 資源タイプ | ||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
| 資源タイプ | journal article | |||||||||
| アクセス権 | ||||||||||
| アクセス権 | open access | |||||||||
| アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||||
| その他のタイトル | ||||||||||
| その他のタイトル | Gadoxetic Acid-enhanced Liver MRI | |||||||||
| 著者 |
Ichikawa, Shintaro
× Ichikawa, Shintaro
× Goshima, Satoshi
|
|||||||||
| 書誌情報 |
en : Investigative Radiology 巻 59, 号 1, p. 53-68, 発行日 2024-01 |
|||||||||
| 出版者 | ||||||||||
| 出版者 | Wolters Kluwer Health | |||||||||
| 言語 | en | |||||||||
| 権利 | ||||||||||
| 権利情報 | This is a non-final version of an article published in final form in "Investigative radiology, Vol.59 No.1, pp53-68". | |||||||||
| 抄録 | ||||||||||
| 内容記述タイプ | Abstract | |||||||||
| 内容記述 | Since its introduction in the worldwide medical market, gadoxetic acid has attracted considerable interest. The year 2023 marks the 15th anniversary of the introduction of gadoxetic acid in Japan. Gadoxetic acid-enhanced magnetic resonance imaging (GA-MRI) is the predominantly performed contrast MRI examination for the liver. Its most essential characteristic, namely the hepatobiliary phase, revolutionized the clinical management of liver disease. GA-MRI is currently the most efficient method for focal liver lesion detection and analysis. Meta-analyses demonstrated its excellent effectiveness for the diagnosis of hepatocellular carcinoma and liver metastases. Owing to the extensive usage of gadoxetic acid, a hepatobiliary phase hypointense nodule without arterial phase hyperenhancement is well documented. The existence of such nodules may be a sign of hypervascular hepatocellular carcinoma in nodules and other areas in the liver. Apart from its role in tumor identification and characterization, GA-MRI can help assess response to therapy and liver fibrosis. Therefore, it is proposed to use gadoxetic acid as the first option for MRI of the liver in the majority of patients. The efficacy of gadoxetic acid surpasses its disadvantages, rendering this contrast agent the preferred choice for routine MRI of the liver. The clinical use of GA-MRI is discussed in this review article. | |||||||||
| EISSN | ||||||||||
| 収録物識別子タイプ | EISSN | |||||||||
| 収録物識別子 | 1536-0210 | |||||||||
| NII書誌ID | ||||||||||
| 収録物識別子タイプ | NCID | |||||||||
| 収録物識別子 | AA00683747 | |||||||||
| PubMed番号 | ||||||||||
| 関連タイプ | isVersionOf | |||||||||
| 識別子タイプ | PMID | |||||||||
| 関連識別子 | 37227150 | |||||||||
| 出版社DOI | ||||||||||
| 関連タイプ | isVersionOf | |||||||||
| 識別子タイプ | DOI | |||||||||
| 関連識別子 | https://doi.org/10.1097/RLI.0000000000000990 | |||||||||
| 著者版フラグ | ||||||||||
| 出版タイプ | AM | |||||||||
| 出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||||||
